AbbVie Teams Up With Valkai to Use AI in Clinical Development
Article excerpt
Highlighted: the sentence this signal was extracted from
AbbVie (ABBV) said Tuesday it is investing in its artificial intelligence infrastructure by collaborating with life sciences AI platform Valkai. Under the partnership, AbbVie said it will deploy AI technology to improve efficiency in targeted areas of clinical research, generate insights more quickly, and support opportunities to reduce development timelines. Financial details were not provided.
